813
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The Urinary and Serum Levels of IL-32 in Children with Febrile Urinary Tract Infections

, , , &
Article: FSO242 | Received 12 Jun 2017, Accepted 10 Aug 2017, Published online: 14 Sep 2017

References

  • Becknell B, Schober M, Korbel L, Spencer JD. The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev. Anti. Infect. Ther. 13(1), 81–90 (2015).
  • Karavanaki KA, Soldatou A, Koufadaki AM, Tsentidis C, Haliotis FA, Stefanidis CJ. Delayed treatment of the first febrile urinary tract infection in early childhood increased the risk of renal scarring. Acta Paediatr. 106(1), 149–154 (2017).
  • Rodriguez Azor B, Ramos Fernandez JM, Sanchiz Cardenas S et al. [Renal scarring in children under 36 months hospitalised for acute pyelonephritis]. Anales de pediatria 86(2), 76–80 (2017).
  • Uyar Aksu N, Ekinci Z, Dundar D, Baydemir C. Childhood urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria: risk factors and empiric therapy. Pediatr. Int. 59(2), 176–180 (2017).
  • Svanborg C. Urinary tract infections in children: microbial virulence versus host susceptibility. Adv. Exp. Med. Biol. 764, 205–210 (2013).
  • Strohmeier Y, Hodson EM, Willis NS, Webster AC, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst. Rev. 28(7), CD003772 (2014).
  • Slabbaert K, Bogaert G. Vesicoureteric reflux (VUR) in children: where are we now? Arch. Esp. Urol. 65(4), 450–458 (2012).
  • Bocquet N, Biebuyck N, Lortat Jacob S, Aigrain Y, Salomon R, Cheron G. [Imaging strategy for children after a first episode of pyelonephritis]. Arch. Pediatr. 22(5), 547–553 (2015).
  • Renata Y, Jassar H, Katz R, Hochberg A, Nir R-R, Klein-Kremer A. Urinary concentration of cytokines in children with acute pyelonephritis. Eur. J. Pediatr. 172(6), 769–774 (2013).
  • Kassem J, Wasilewska A, Zoch-Zwierz W. Urinary concentration of proinflammatory cytokines with regard to infected urinary tract region. Wiad. Lek. 58, 14–19 (2004).
  • Mansour SG, Puthumana J, Coca SG, Gentry M, Parikh CR. Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. BMC Nephrol. 18(1), 72 (2017).
  • Janak JC, Stewart IJ, Sosnov JA et al. Urinary biomarkers are associated with severity and mechanism of injury. Shock 47(5), 593–598 (2017).
  • Ribeiro-Dias F, Saar Gomes R, de Lima Silva LL, Dos Santos JC, Joosten LA. Interleukin 32: a novel player in the control of infectious diseases. J. Leukoc. Biol. 101(1), 39–52 (2017).
  • Zhou Y, Zhu Y. Important role of the IL-32 inflammatory network in the host response against viral infection. Viruses 7(6), 3116–3129 (2015).
  • Maeurer M, Rao M, Zumla A. Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32. Ann. Transl. Med. 3(Suppl. 1), S37 (2015).
  • Lee DH, Kim DH, Hwang CJ et al. Interleukin-32gamma attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses. Clin. Sci. 128(10), 695–706 (2015).
  • Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS, Kim HM. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J. Pathol. 224(4), 553–563 (2011).
  • Soyka M, Treis A, Eiwegger T et al. Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy 67(6), 790–798 (2012).
  • Inoue M, Shoda H, Seri Y et al. Three cases of lupus nephritis patients with serum interleukin-32γ detection. Lupus. 23(11), 1187–1191 (2014).
  • Kim S. Interleukin-32 in inflammatory autoimmune diseases. Immune Netw. 14(3), 123–127 (2014).
  • Monteleone K, Di Maio P, Cacciotti G et al. Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients. Med. Microbiol. Immunol. 203(3), 207–216 (2014).
  • Jantausch BA, O’Donnell R, Wiedermann BL. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr. Nephrol. 15(3–4), 236–240 (2000).
  • Sheu J-N, Chen M-C, Lue K-H et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine 36(5), 276–282 (2006).
  • Renata Y, Jassar H, Katz R, Hochberg A, Nir RR, Klein-Kremer A. Urinary concentration of cytokines in children with acute pyelonephritis. Eur. J. Pediatr. 172(6), 769–774 (2013).
  • Krzemień G, Szmigielska A, Turczyn A, Panczyk-Tomaszewska M. Urine interleukin-6, interleukin-8 and transforming growth factor beta1 in infants with urinary tract infection and asymptomatic bacteriuria. Cent. Eur. J. Immunol. 41(3), 260–267 (2016).
  • Sheu J-N, Chen S-M, Meng M-H, Lue K-H. The role of serum and urine interleukin-8 on acute pyelonephritis and subsequent renal scarring in children. Pediatr. Infect. Dis. J. 28(10), 885–890 (2009).
  • Sheu JN, Chen MC, Cheng SL, Lee IC, Chen SM, Tsay GJ. Urine interleukin-1β in children with acute pyelonephritis and renal scarring. Nephrology 12(5), 487–493 (2007).
  • Tramma D, Hatzistylianou M, Gerasimou G, Lafazanis V. Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring. Pediatr. Nephrol. 27(9), 1525–1530 (2012).
  • Sheu J-N, Chen M-C, Chen S-M, Chen S-L, Chiou S-Y, Lue K-H. Relationship between serum and urine interleukin-6 elevations and renal scarring in children with acute pyelonephritis. Scand. J. Urol. Nephrol. 43(2), 133–137 (2009).
  • Galanakis E, Bitsori M, Dimitriou H, Giannakopoulou C, Karkavitsas NS, Kalmanti M. Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Pediatrics 117(5), E863–E867 (2006).
  • Haraoka M, Senoh K, Ogata N, Furukawa M, Matsumoto T, Kumazawa J. Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. J. Urol. 155(2), 678–680 (1996).
  • Mahyar A, Ayazi P, Yarigarravesh MH et al. Serum interleukin −8 is not a reliable marker for prediction of vesicoureteral reflux in children with febrile urinary tract infection. Int. Braz. J. Urol. 41(6), 1160–1166 (2015).